Recurrent Hepatocellular Carcinoma Clinical Trials in Birmingham, Alabama
2 recruitingBirmingham, Alabama
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more
Children's Oncology Group147 enrolled21 locationsNCT04851119
Recruiting
Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
Recurrent Hepatocellular Carcinoma
Emory University19 enrolled3 locationsNCT05103904